$O

These dividend stocks have slashed their payments, Morgan Stanley says

Morgan Stanley says dividend cuts can reflect financial pressure, particularly from higher interest rates that raise debt costs. It notes stocks often fall for six months after a cut, then may outperform as balance sheets improve. Examples: Healthcare Realty Trust cut its dividend 23% to 24 cents; Dow halved to 35 cents.

Original reporting
Published Jun 9, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 9, 2026, 9:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
These dividend stocks have slashed their payments, Morgan Stanley says — source image
Decision brief

The 30-second read

$ONeutralLow
01

Why it matters

The piece frames dividend cuts as a balance-sheet repair that can eventually support outperformance after the initial selloff, but it provides limited new company-specific updates beyond O and DOW.

02

Market read

Useful for income/credit positioning: the article supports a framework that dividend cuts can be followed by a recovery trade once the market prices in the risk.

03

What to watch

The article doesn’t quantify each company’s refinancing schedule, leverage metrics, or coverage ratios—key drivers of whether dividend recovery is realistic versus merely narrative-driven.

Relevance 5/10Novelty 4/10Timing: after Morgan Stanley’s late-May report; relevant for positioning around dividend-sustainability/rate sensitivity

Background

Morgan Stanley screened companies that slashed dividends by at least 15% in the prior 12 months, arguing higher rates and debt costs can force payout reductions.

Company-level read

Ticker impact

$ONeutralMedium confidence
Context

Morgan Stanley’s list highlights Healthcare Realty Trust (O) after it slashed its dividend 23% last July to manage refinancing risk and retain earnings.

Expected impact

Choppy/underperforming initially, with potential mean-reversion if financial flexibility improves.

Evidence & confidence

The article provides the magnitude and stated rationale for the cut, plus that shares are up in 2026—suggesting the market may already be partially pricing recovery.

$DOWNeutralMedium confidence
Context

Dow (DOW) is cited for halving its dividend last July to 35 cents a share, aiming to align payout with financial flexibility.

Expected impact

Moderate positive bias if investors view the cut as enabling higher-return projects; otherwise dividend-sensitive selling risk persists.

Evidence & confidence

The article includes the company’s own stated rationale and current yield/price performance, but it’s still an analyst/strategy framing rather than a fresh corporate action.

$LYBNeutralLow confidence
Context

LyondellBasell (LYB) is included on Morgan Stanley’s dividend-cut screen, implying payout pressure tied to debt/interest-rate sensitivity.

Expected impact

Potential downside skew for income holders if further cuts are expected; otherwise limited immediate impact without a new cut announcement.

Evidence & confidence

The article names LYB as part of the list but does not provide a specific new dividend change or company-specific update for LYB.

$DDNeutralLow confidence
Context

DuPont (DD) appears on Morgan Stanley’s list of companies that cut dividends by at least 15% in the past 12 months.

Expected impact

Likely limited incremental impact unless the market interprets the screen as signaling further balance-sheet stress.

Evidence & confidence

No new DD-specific dividend action or quote is provided beyond being listed.

$BAXNeutralLow confidence
Context

Baxter International (BAX) is named among dividend cutters Morgan Stanley screened for at least a 15% cut over 12 months.

Expected impact

Neutral-to-negative near-term if investors extrapolate further cuts; otherwise minimal incremental effect.

Evidence & confidence

The article does not disclose a fresh BAX dividend decision or new fundamental datapoint.

$ARENeutralLow confidence
Context

Alexandria Real Estate Equities (ARE) is included on Morgan Stanley’s dividend-cut list, indicating payout reductions tied to financing conditions.

Expected impact

Potential underperformance versus peers if rates stay high and refinancing remains a concern.

Evidence & confidence

ARE is only mentioned as part of the list; no new ARE-specific details are provided.

Market effects

Reinforces a read-across that dividend sustainability is increasingly rate/credit sensitive, especially for leveraged balance sheets and REIT-style cash flows.

Primarily US-focused income/credit sentiment; could influence broader US dividend/financial conditions trades.

Higher-for-longer rates narrative can transmit to global dividend/credit risk premia, but the article’s actionable content is US-centric.

Counterpoint

Dividend cuts may not be a “buy-the-dip” setup if the underlying cash-flow stress persists; the screen could be catching companies where recovery is slower than the strategist assumes.

Key entities

  • Healthcare Realty Trust

    Cut its dividend 23% last July to manage refinancing risk and fund retained earnings; cited as an example on Morgan Stanley’s list.

  • Dow Inc.

    Halved its dividend last July to 35 cents a share to increase financial flexibility; cited with current yield and 2026 performance.

  • Morgan Stanley

    Published the dividend-cut screen and the strategist thesis about initial underperformance followed by potential recovery.

  • Federal Reserve

    Maintained rates since Dec 2025; higher-for-longer backdrop is used to explain dividend pressure.

Related articles

$BAXMedAI 8/10

Why Baxter International Stock Skyrocketed by 19% This Week

Baxter International shares rose about 19% this week after the company reported a Q2 earnings beat and raised full-year guidance, according to S&P Global Market Intelligence and Baxter. Q2 sales were $2.96B, up 5% year over year, and GAAP net income rose to $135M. Baxter now expects 2025 sales growth of 3% to 4% and adjusted EPS of $1.95 to $2.15.

$DDMedAI 8/10

New Jersey Judge Approves $2.5 Billion PFAS Settlements With DuPont and 3M

A New Jersey federal judge approved PFAS settlements totaling over $2.5 billion with DuPont, Chemours, Corteva and 3M, Reuters reported. The deals require cleanup of four former sites and compensation for natural-resource damages, including a $1.2 billion restoration fund. DuPont, Chemours and Corteva pay $875 million over 25 years; 3M pays $400-$450 million, plus a $475 million reserve.

$DDMedAI 8/10

New Jersey’s $2.5 billion ’forever chemicals’ settlements with DuPont, 3M, others win court approval

A federal judge approved New Jersey’s PFAS settlement totaling over $2.5 billion with DuPont, Chemours, Corteva and 3M, according to Reuters. DuPont, Chemours and Corteva will pay $875 million over 25 years, including site cleanup and a $1.2 billion remediation fund. 3M will pay $400 million to $450 million. The ruling overruled municipal objections.

$LYBMed

Iran conflict lifts chemical earnings

Iran conflict and Strait of Hormuz disruption have tightened petrochemical supply, enabling major chemical makers to raise prices. LyondellBasell reported Q2 adjusted earnings of $1.4B, up nearly 600% YoY. Dow sales rose 19.7% and swung to profit. BASF profits rose 167% with 16% higher sales. Executives warn the boost may be temporary.